###begin article-title 0
###xml 83 85 83 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 124 131 124 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo</italic>
###xml 16 21 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 102 107 <span type="species:ncbi:9606">human</span>
Determinants in HIV-1 Nef for enhancement of virus replication and depletion of CD4+ T lymphocytes in human lymphoid tissue ex vivo
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 394 401 394 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 531 533 531 533 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 571 578 571 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo</italic>
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 151 154 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 264 267 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 285 290 <span type="species:ncbi:9606">human</span>
###xml 499 504 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Nef critically contributes to AIDS in part by augmenting virus titers in infected individuals. Analyzing which of Nef's activities contribute to HIV pathogenesis has been hampered by the lack of a cell culture model in which Nef exerts pronounced effects on HIV replication. The human lymphoid aggregate culture (HLAC) from tonsil maintains the cell populations and cytokine milieu found in vivo, supports a productive infection without exogenous stimulation, and Nef contributes to efficient HIV-1 replication as well as CD4+ T cell depletion in this experimental ex vivo-model.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 110 116 110 116 <sub xmlns:xlink="http://www.w3.org/1999/xlink">NL4-3 </sub>
###xml 175 179 175 179 <sub xmlns:xlink="http://www.w3.org/1999/xlink">SF2 </sub>
###xml 360 362 360 362 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 602 604 602 604 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 811 813 811 813 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 105 108 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 170 173 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 201 206 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
To identify determinants in Nef that mediate these activities, we infected HLAC with a panel of isogenic HIV-1NL4-3 strains that encode for well-characterized mutants of HIV-1SF2 Nef. Determination of HIV-1 replication revealed that enhancement of the virus spread by Nef is governed by a complex set of protein interaction surfaces. In contrast, increased CD4+ T lymphocyte depletion depended on only two protein interaction surfaces in Nef that mediate either downregulation of cell surface CD4 or interaction with the NAKC signalosome. Consistently, in HLAC from 9 out of 14 donors, Nef enhanced CD4+ T cell depletion in the absence of a significant effect on virus replication. Moreover, our results suggest that this Nef-dependent enhancement in depletion occurred predominately in uninfected bystander CD4+ T cells.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 58 60 58 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 108 116 108 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo </italic>
###xml 278 285 278 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 77 82 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Our findings suggest that Nef facilitates depletion of CD4+ T lymphocytes in HIV-1-infected lymphoid tissue ex vivo by increasing the pool of productively infected cells and by sensitizing bystander cells for killing. This ability might contribute to Nef's pathogenic potential in vivo.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 144 146 144 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 219 220 219 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 433 435 433 435 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 548 550 548 550 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 679 681 679 681 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 754 755 754 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 756 757 756 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 799 806 799 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 907 914 907 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ex vivo</italic>
###xml 1053 1060 1053 1060 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo</italic>
###xml 1255 1263 1255 1263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 1278 1279 1278 1279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1481 1483 1481 1483 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1561 1562 1561 1562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1563 1565 1563 1565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1583 1588 1583 1588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 1651 1653 1651 1653 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1688 1690 1688 1690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 74 77 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 317 320 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 452 455 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 465 473 <span type="species:ncbi:9606">patients</span>
###xml 531 534 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 535 542 <span type="species:ncbi:9606">patient</span>
###xml 944 949 <span type="species:ncbi:9606">human</span>
###xml 1073 1078 <span type="species:ncbi:9606">human</span>
###xml 1119 1122 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1263 1266 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1362 1365 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1516 1519 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1670 1673 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The clinical manifestation of AIDS results from continuous replication of HIV in infected individuals that causes slow but steady decline of CD4+ T lymphocytes to levels that no longer control opportunistic infections [1]. Despite our expanding knowledge on the molecular details of the multi-faceted interactions of HIV with its host, the basic question of which viral factors and cell death mechanisms contribute to the loss of CD4+ T lymphocytes in HIV infected patients has not been entirely solved. Clearly, the decline of an HIV patient's CD4+ T cell count is caused by the death of infected cells, but it also reflects the increased sensitivity of uninfected bystander CD4+ T cells to undergo apoptosis as well as a reduced regenerative capacity [2-4]. This complex interplay is studied best in vivo; such analysis has, however, been limited by the lack of an infectible small animal model for AIDS. Ex vivo-cultures of lymphoid organs (human lymphoid histoculture, HLH) were therefore established as surrogate experimental systems. Among these, ex vivo-cultures of human tonsils proved particularly valuable as HIV readily replicates to high titers in these cultures that maintain cell composition and cytokine milieu of a primary target organ of in vivo HIV infection [5]. Studies in the tonsil HLH model have shed light on key pathogenic properties of HIV, including cell tropism and cytopathic effects in relation to coreceptor usage, productive infection of resting CD4+ T cells, early host responses to HIV infection as well as viral coinfections [6-16]. Of note, Jekle et al. observed a rapid depletion of mostly uninfected bystander CD4+ T lymphocytes in HIV-infected HLH [17]. Importantly, these effects are observed in HLH cultures even in the absence of exogenous activation, which typically complicates the interpretation of results obtained with e.g. PBMC cultures.
###end p 9
###begin p 10
###xml 212 220 212 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 221 223 221 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 255 259 255 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 359 361 359 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 362 364 362 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 461 464 461 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef</italic>
###xml 482 484 482 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 757 759 757 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 760 762 760 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 799 807 799 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 931 938 931 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo</italic>
###xml 1018 1025 1018 1025 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1172 1174 1172 1174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1175 1177 1175 1177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1280 1282 1280 1282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 1283 1285 1283 1285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 1440 1442 1440 1442 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1536 1538 1536 1538 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1551 1552 1551 1552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1632 1634 1632 1634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 1833 1835 1833 1835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 2046 2048 2046 2048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 2131 2133 2131 2133 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 2150 2157 2150 2157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo</italic>
###xml 71 74 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 147 152 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 160 163 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 465 480 <span type="species:ncbi:10090">transgenic mice</span>
###xml 568 571 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 788 791 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1049 1052 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1610 1615 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1617 1622 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 1627 1630 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 1675 1680 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1774 1777 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
HLH cultures were also instrumental for the functional analysis of the HIV accessory gene product Nef. Nef, a 25-35 kDa protein, is encoded by all HIV-1/-2 and SIV strains and potently augments virus replication in vivo [18]. Consequently, defects in the nef gene lead to reduced virus replication in the host and thus delayed or aborted disease progression [19-21]. Together with the observation that Nef alone is sufficient to imprint AIDS-like phenotypes in nef-transgenic mice [22], these findings establish Nef as a central factor for the pathogenic potential of HIV. Molecular analyses have identified a series of host cell transport and signal transduction processes that are disturbed by Nef via its many protein interactions with cellular factors [23-26]. How exactly Nef boosts HIV spread in vivo has, however, remained largely unclear. This lack of knowledge is in particular due to the fact that so far no experimental ex vivo-cell system faithfully reflects the strong impact Nef has on virus replication in vivo. While dispensable for HIV replication in T cell lines, a moderate increase of virus replication is provided by Nef in cultures of isolated PBLs [27-30] and Nef also augments virus replication in cocultures of antigen presenting cells and T lymphocytes [31-34]. Since these systems only allow the monitoring of virus spread, HLH cultures were employed to additionally analyze the effects of Nef on depletion of CD4+ T lymphocytes and revealed a significant contribution of Nef to both virus replication and CD4+ T cell loss [8], an activity that is conserved across Nef variants from HIV-1, HIV-2 and SIV [35]. Analysis of Nef proteins from various HIV-1 strains indicated that this activity of Nef may be linked to its ability to downregulate the HIV entry receptor CD4 from the surface of infected cells [36]. Molecular determinants that govern Nef's activity in HLH cultures have not yet been identified. In this study we therefore made use of a panel of isogenic viruses that express well characterized Nef mutants [27] and determined their replication kinetics as well as their ability to deplete CD4+ T lymphocytes in ex vivo-lymphoid tissue culture.
###end p 10
###begin title 11
Results
###end title 11
###begin title 12
###xml 51 53 51 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 13 18 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Nef augments HIV-1 replication and depletion of CD4+ T lymphocytes in ex vivo-tonsil cultures
###end title 12
###begin p 13
###xml 97 99 97 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 116 123 116 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo</italic>
###xml 306 308 306 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 417 420 417 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef</italic>
###xml 447 450 443 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef</italic>
###xml 582 584 578 580 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 827 831 819 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 873 875 865 867 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 1079 1081 1071 1073 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 136 141 <span type="species:ncbi:9606">human</span>
###xml 161 164 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 264 269 <span type="species:ncbi:9606">human</span>
###xml 430 435 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 437 440 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 831 836 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1055 1060 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
We first sought to establish the overall effect Nef has on virus replication and depletion of CD4+ T lymphocytes in ex vivo-cultures of human tonsil tissue from HIV-negative donors. Such cultures can be established as tissue blocks or in suspension as aggregates (human lymphoid aggregate cultures, HLAC) [12]. Initial parallel testing of both experimental systems gave identical results for the comparison of wt and nef-negative HIV-1 (HIV-1Deltanef) (data not shown). We also compared normalization of virus input based on amounts of viral antigen (p24) or virus infectivity (TCID50) and again did not observe significant differences (data not shown). We therefore employed HLAC and virus inoculum normalization by p24 ELISA for the remainder of this study. HLAC were infected one day after cell preparation with wt and Deltanef HIV-1 corresponding to 3 ng p24 per 2 x 106 cells. 24 h later the virus input was washed out and the HLAC maintained for 11 more days. On day 4, 8, and 12 p.i., cell culture supernatant was analyzed by p24 ELISA to quantify HIV-1 production and CD4+ T cell depletion was determined by flow cytometry. Quadruplicate parallel infections were harvested for each time point.
###end p 13
###begin p 14
###xml 5 7 5 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 408 409 408 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 442 443 442 443 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 447 449 447 449 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 473 475 473 475 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 556 558 556 558 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 733 735 733 735 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 828 830 828 830 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 878 880 878 880 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 980 984 976 980 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 1025 1027 1021 1023 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1169 1171 1165 1167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1172 1174 1168 1170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1175 1177 1171 1173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 1226 1228 1222 1224 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1267 1269 1263 1265 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1276 1278 1272 1274 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1368 1370 1364 1366 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1510 1512 1502 1504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 1535 1538 1523 1526 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef</italic>
###xml 1574 1576 1562 1564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 1645 1647 1633 1635 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1716 1718 1704 1706 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1749 1751 1737 1739 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1757 1759 1745 1747 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1944 1953 1932 1937 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#916;nef </italic>
###xml 1959 1961 1943 1945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 2088 2092 2068 2072 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 2471 2473 2451 2453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 2577 2579 2557 2559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 2767 2776 2747 2752 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#916;nef </italic>
###xml 2782 2784 2758 2760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 2884 2886 2860 2862 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 2912 2919 2888 2895 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo</italic>
###xml 2953 2954 2929 2930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 2955 2957 2931 2933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 250 255 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 699 704 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 851 856 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 970 973 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1517 1522 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1883 1888 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1939 1942 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1991 1996 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2078 2081 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 2138 2141 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 2232 2237 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2722 2727 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2762 2765 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 2859 2864 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2932 2937 <span type="species:ncbi:9606">human</span>
Fig. 1A presents the results of such an analysis 12 days p.i.: viable lymphocytes were identified in the FSC/SSC (gate R1) and analyzed for expression of CD3 and CD8. Direct staining of CD4 was avoided due to the reduction of CD4 surface exposure in HIV-1 infected cells, but a control staining for mock infected cells reveals that virtually all cells in this gate were positive for CD4 (see Additional file 1). A pronounced population of CD3+/CD8- cells that represent CD4+ T lymphocytes was found in mock-infected cultures (53.8% of all lymphocytes). CD8+ T lymphocytes were less abundant (7.4%) and approximately 40% of all cells in the lymphocyte gate did not carry these T cell markers. In the HIV-1 wt infected culture, the CD4+ population was markedly reduced to 14.6%, reflecting the strong and specific depletion of CD4+ T lymphocytes due to HIV-1 replication. This CD4+ T lymphocyte depletion was significantly less pronounced in the culture infected with the HIV-1Deltanef virus that maintained 34.9% of viable CD4+ T lymphocytes. To normalize for variations in cell populations between different donors/experiments, we employed a well-established strategy [11,17,36], which determines the relative abundance of CD4+ T cells by calculating the ratio of CD4+ and CD8+ T lymphocytes with values for mock-infected cultures set to 100%. Accordingly, average CD4+ T lymphocyte depletion of 83.8 +/- 5.1% and 54.2 +/- 1.0% was observed in parallel quadruplicate infections of the experiment shown in Fig. 1A for HIV-1 wt- or Deltanef- infected HLAC, respectively (Fig. 1B). Control analyses confirmed that virtually identical degrees of CD4+ T lymphocyte depletion were obtained by using the total amount of CD4+ lymphocytes rather than the CD4+ to CD8+ ratio for evaluation (data not shown). Quantification of viral p24 antigen over the time course of infection showed that wt HIV-1 replicated more rapidly and to higher levels than HIV-1Deltanef (Fig. 1C). In HLAC from a few donors, HIV-1 replication was overall accelerated, resulting in late peak virus production for HIV-1Deltanef that was comparable to that observed early in HIV-1wt infected cultures, indicating that the lack of Nef delays but not generally abrogates HIV-1 replication in HLAC (data not shown). To facilitate assessment of overall virus production during the time course of infection, the integral area under the curve (AUC) was calculated from the p24 replication kinetics plot (e.g. Fig. 1C). This evaluation accounts best for changes in p24 concentration in the cell culture medium over time [13]. Plotting of the mean AUC of the independent quadruplicates analyzed in parallel revealed that over 3-times more p24 were produced in the wt HIV-1-infected culture when compared to HIV-1Deltanef (Fig. 1D). These results recapitulate the previously described phenotype of Nef on HIV-1 replication and CD4+ T lymphocyte depletion in ex vivo-cultures of human tonsil tissue [8,36] and provide the experimental framework to perform standardized multi-donor HLAC analyses and map Nef determinants that are critical for these activities.
###end p 14
###begin p 15
###xml 3 5 3 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 66 69 62 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef</italic>
###xml 111 118 107 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo</italic>
###xml 0 118 0 114 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CD4<sup>+ </sup>T cell depletion and viral replication in HIV-1 wt- and &#916;<italic>nef</italic>-infected cultures of human tonsil tissue <italic>ex vivo</italic></bold>
###xml 209 212 201 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef</italic>
###xml 464 466 456 458 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 473 475 465 467 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 47 52 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 91 96 <span type="species:ncbi:9606">human</span>
###xml 191 196 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
CD4+ T cell depletion and viral replication in HIV-1 wt- and Deltanef-infected cultures of human tonsil tissue ex vivo. HLACs were infected in quadruplicates with equal amounts (3 ng p24) of HIV-1 wt and Deltanef. Results for one such quadruplicate are shown in A and C, B and D depict mean values and SD of quadruplicate infections analyzed in parallel. (A) HLACs were stained on day 12 p.i. for CD3 and CD8 and analyzed in flow cytometry to assess numbers of CD4+ and CD8+ T cells. (B) CD4/CD8 ratios of infected cultures were calculated, and the percentage of CD4 T lymphocyte depletion was plotted relative to mock-infected cultures that were arbitrarily set to 0%. (C) Concentration of p24 in the culture medium over time as determined by p24 ELISA at the indicated time points. (D) p24 production over the culture period (area under the curve, AUC) of the graphs shown in C. Shown is the mean and standard deviation of all quadruplicates.
###end p 15
###begin p 16
###xml 90 92 90 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 125 134 125 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#916;nef </italic>
###xml 340 342 336 338 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 402 405 398 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef</italic>
###xml 483 486 473 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef</italic>
###xml 521 526 509 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A, C</xref>
###xml 669 674 651 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef: </italic>
###xml 714 719 694 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B, D</xref>
###xml 820 822 800 802 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 934 943 914 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#916;nef </italic>
###xml 955 957 931 933 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1064 1069 1040 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A, C</xref>
###xml 1095 1104 1071 1076 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#916;nef </italic>
###xml 1215 1217 1187 1189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 1383 1392 1355 1360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#916;nef </italic>
###xml 1495 1497 1463 1465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 1609 1618 1577 1582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#916;nef </italic>
###xml 1679 1681 1641 1643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 1723 1725 1685 1687 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1781 1789 1743 1747 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#916;nef</italic>
###xml 1911 1921 1867 1873 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#916;nef: </italic>
###xml 1980 1989 1928 1933 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#916;nef </italic>
###xml 2036 2038 1978 1980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 2185 2195 2125 2131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#916;nef: </italic>
###xml 2239 2241 2173 2175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 2306 2308 2240 2242 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 2341 2350 2275 2280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#916;nef </italic>
###xml 2382 2392 2310 2316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#916;nef: </italic>
###xml 2575 2577 2497 2499 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 2723 2725 2645 2647 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 2797 2799 2719 2721 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 134 139 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 450 455 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 929 932 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1021 1026 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1090 1093 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1169 1174 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1392 1397 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1618 1623 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1775 1780 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1814 1819 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2251 2256 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2336 2339 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 2550 2555 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2685 2690 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Using the experimental set-up described above, we first compared virus replication and CD4+ T lymphocyte depletion of wt and Deltanef HIV-1 using tonsils from 14 donors in 35 independent experiments, e.g. with independent virus stocks, with quadruplicate parallel infections for each time point analyzed. These studies demonstrated that CD4+ T lymphocyte depletion was consistently less severe for the nef-deficient virus compared to the isogenic wt HIV-1 (wt: 84.4 +/- 1.4% vs Deltanef: 53.8 +/- 1.4%; p < 0.0001) (Fig. 2A, C). Similarly, p24 production and thus virus replication was also significantly reduced in the absence of Nef (wt: (mean) 251.1 +/- 9.8 vs Deltanef: (mean) 134.1 +/- 4.6; p = 0.0001) (Fig. 2B, D), suggesting, for this cross-donor analysis, a correlation between virus replication and loss of CD4+ T lymphocytes. Upon closer examination of the results for HLAC from individual donors, we noted that while HIV-1Deltanef depleted CD4+ T lymphocytes less vigorously than an average infection with wt HIV-1 in essentially all experiments (Fig. 2A, C), p24 production by HIV-1Deltanef reached levels in the range of the highest ones obtained with wt HIV-1, in some, but not all experiments (Fig. 2B). To explore this further, we stratified results obtained for individual donor HLAC according to p24 production into two groups: the first, for which AUC values for Deltanef HIV-1 were statistically lower than those of wt (p < 0.05, 18 experiments; different replication; Fig. 3A), and the second, for which the AUC values did not reveal statistically significant differences between wt and Deltanef HIV-1 (p >/= 0.05, 17 experiments; similar replication; Fig. 3B). Expectedly, both p24 production and CD4+ T lymphocyte depletion were markedly decreased in HIV-1 Deltanef-infected relative to wt HIV-1-infected cultures in the "different replication" cohort (production: wt: 248.9 +/- 13.4 vs Deltanef: 79.3 +/- 5.7 (p < 0.0001); depletion: wt 84.5 +/- 1.9% vs. Deltanef 50.7 +/- 2.1% (p < 0.0001); mean values) (Fig. 3A). In the "similar replication" cohort p24 production was, expectedly, statistically indistinguishable between both viruses (wt: 253.0 +/- 14.7 vs Deltanef: 202.1 +/- 7.0; p = 0.26; mean values) (Fig. 3B), but wt HIV-1 infection still resulted in a more pronounced CD4+ T lymphocyte depletion than HIV-1Deltanef infection (wt: 84.4 +/- 2.2% vs Deltanef: 57.2 +/- 2.0%, mean values), with a high statistical significance (p < 0.0001). In line with these findings, no statistically significant correlation between HIV-1 replication and CD4+ T lymphocyte depletion was observed (data not shown). These multi-donor studies demonstrate that Nef boosts HIV-1 replication and depletion of CD4+ T lymphocytes in HLAC, and suggests that Nef's effect on the loss of CD4+ T lymphocytes is not strictly coupled to the elevation of virus spread.
###end p 16
###begin p 17
###xml 3 5 3 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 59 63 55 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 0 99 0 95 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CD4<sup>+ </sup>T cell depletion and viral replication of wt and &#916;<italic>nef </italic>HIV-1 in tonsils from 35 experiments</bold>
###xml 111 113 107 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 63 68 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
CD4+ T cell depletion and viral replication of wt and Deltanef HIV-1 in tonsils from 35 experiments. (A, B) CD4+ T cell depletion (A) and p24 production (B). Each data point represents the mean value of quadruplicate parallel infections. p-values indicate statistical significance by Mann-Whitney-U analysis. (C, D) Boxplot presentation of the data shown in A and B. Boxes indicate the upper and lower quartile (box borders), median (line within the box) and the maxima and minima of each data set (vertical lines).
###end p 17
###begin p 18
###xml 3 5 3 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 59 63 55 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 0 88 0 84 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CD4<sup>+ </sup>T cell depletion and viral replication of wt and &#916;<italic>nef </italic>HIV-1 in selected cohorts</bold>
###xml 223 227 215 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 293 297 281 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 532 534 520 522 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 866 875 854 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#916;nef </italic>
###xml 63 68 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 297 302 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
CD4+ T cell depletion and viral replication of wt and Deltanef HIV-1 in selected cohorts. Experimental data analyzed in Fig. 2 were divided into two groups based on differences in p24 production established for wt and Deltanef viruses. Experiments, in which p24 production between wt and Deltanef HIV-1 differed significantly (p > 0.05) were grouped as "different replication" (A). Experiments without significant difference (p < 0.05) in p24 production were considered as "similar replication" (B). Shown are p24 production and CD4+ T cell depletion of all individual experiments (left panels). p-values indicate statistical significance by Mann-Whitney-U analysis. The middle panels are boxplot presentations of the data on the left with the indicated upper and lower quartile, median, maxima and minima. In the right panels, data are presented to identify wt and Deltanef pairs analyzed in parallel.
###end p 18
###begin title 19
###xml 88 90 88 90 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
Nef employs two distinct protein interaction surfaces to facilitate the depletion of CD4+ T lymphocytes in HLAC
###end title 19
###begin p 20
###xml 75 82 75 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo</italic>
###xml 220 222 220 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 230 231 230 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 306 315 306 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#916;nef </italic>
###xml 422 424 418 420 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 573 575 569 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 672 676 660 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 1047 1049 1031 1033 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1069 1071 1053 1055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 1459 1461 1443 1445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 1555 1557 1539 1541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1861 1863 1845 1847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1864 1866 1848 1850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1979 1981 1963 1965 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 2117 2119 2097 2099 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 2406 2408 2382 2384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 2646 2648 2618 2620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 2649 2651 2621 2623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 2860 2862 2832 2834 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 157 162 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 293 298 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 471 476 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1176 1181 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2632 2637 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2742 2747 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2758 2763 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2918 2923 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
To determine the molecular determinants that govern Nef's activity in this ex vivo-model, tonsil aggregate cultures were challenged with a panel of isogenic HIV-1 NL4-3 viruses coding for characterized SF2 Nef variants [27]. Fig. 4 summarizes the results from up to 12 individual experiments. HIV-1 wt and Deltanef served as reference controls and showed the expected and statistically highly significant difference in CD4+ T cell depletion and p24 production. While all HIV-1 infections with the analyzed Nef mutants displayed apparently intermediate p24 production (Fig. 4A), this difference only reached low statistical significance for NefLLAA and NefDelta12-39 (Deltanef p = 0.0017, G2A p = 0.16, E4A4 p = 0.19, AxxA p = 0.12, LLAA p = 0.03, KKAA p = 0.33, Delta12-39 p = 0.026). When compared among them, virus production between these various Nef mutant viruses was statistically indistinguishable. Despite these comparable intermediate levels of virus production, specific Nef mutants significantly differed in their ability to deplete CD4+ T lymphocytes (Fig. 4B). Four of the analyzed mutants were statistically indistinguishable in their depletion activity from wt HIV-1. This included the G2A and KKAA mutants that lack N-terminal myristoylation or membrane microdomain targeting signals, respectively, and thus display reduced membrane binding (G2A) or lack membrane microdomain incorporation (KKAA) (G2A: 79.5%, p = 0.93; KKAA: 79.9%, p = 1.0) [37]. The two other mutants, E4A4 and AxxA, are not disturbed in their subcellular localization [27], but lack protein interaction motifs for the phosphofurin acidic cluster sorting protein (PACS) sorting adaptor (E4A4) or SH3 domains (AxxA), and are deficient in modulating MHC class I cell surface levels and cell activation, respectively (E4A4: 79.1%, p = 0.899; AxxA: 80.9%, p = 0.93) (reviewed in [24,25]). The lack of requirement for these motifs suggested that these activities are dispensable for Nef-mediated CD4+ T lymphocyte depletion in HLAC infections. In contrast, the two other Nef mutants LLAA and Delta12-39 were significantly impaired in CD4+ T lymphocyte depletion, displaying only partial activity relative to wt (LLAA: 58.6%, p = 0.0002; Delta12-39: 55.6%, p = 0.0005). NefLLAA fails to interact with the endocytic machinery responsible to internalize CD4 and is thus defective in downregulating cell surface CD4 (reviewed in [38]). The Delta12-39 Nef variant, in contrast, is fully active in CD4 downregulation but lacks the interaction surface for the Nef-associated kinase complex (NAKC), a multiprotein complex that facilitates transcription of the HIV-1 genome [39,40]. These results reveal that Nef requires a complex set of molecular determinants to boost HIV-1 spread in HIV-1-infected HLAC and identify two independent protein interaction motifs in Nef that facilitate CD4+ T lymphocyte depletion independently of their effect on HIV-1 replication.
###end p 20
###begin p 21
###xml 0 62 0 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Molecular determinants for Nef's activity in HIV-infected HLAC</bold>
###xml 111 120 111 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#916;nef </italic>
###xml 244 246 240 242 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 45 48 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 104 109 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 120 125 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 129 134 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Molecular determinants for Nef's activity in HIV-infected HLAC. HLACs were infected with 3 ng p24 of wt HIV-1, Deltanef HIV-1 or HIV-1 encoding for the indicated Nef mutants in quadruplicates. (A) p24 production over the culture period. (B) CD4+ T cell depletion on day 12 p.i. Asterisks indicate statistical significance by Mann-Whitney-U analysis (*** p </= 0.0005, ** p < 0.005, * p < 0.05). The top panels present mean values of all individual experiments (n = 7-12), bottom panels are boxplots of the data shown on the top with the indicated upper and lower quartile, median, maxima and minima.
###end p 21
###begin title 22
###xml 25 27 25 27 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 38 41 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Nef enforces death of CD4+ T cells in HIV-infected HLAC
###end title 22
###begin p 23
###xml 55 57 55 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 215 217 215 217 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 685 687 685 687 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 980 984 976 980 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 1100 1102 1092 1094 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1153 1154 1145 1146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 1223 1225 1215 1217 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1261 1262 1253 1254 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1266 1268 1258 1260 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 1357 1359 1349 1351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 1376 1378 1368 1370 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1460 1462 1452 1454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 1576 1578 1568 1570 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1719 1721 1711 1713 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1874 1876 1866 1868 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1907 1909 1899 1901 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1912 1913 1904 1905 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1956 1958 1948 1950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5D</xref>
###xml 2017 2018 2009 2010 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 2022 2024 2014 2016 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 2047 2049 2039 2041 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 2080 2082 2072 2074 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 2085 2087 2077 2079 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 2191 2193 2183 2185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5E</xref>
###xml 2225 2227 2217 2219 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 2299 2303 2287 2291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 2320 2322 2308 2310 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 2353 2355 2341 2343 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 2358 2360 2346 2348 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 2433 2435 2421 2423 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 2523 2527 2507 2511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 2558 2560 2542 2544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5C</xref>
###xml 2896 2897 2880 2881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 2927 2929 2911 2913 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 3025 3027 3009 3011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 3108 3113 3086 3091 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef: </italic>
###xml 3325 3329 3297 3301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 3358 3360 3330 3332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 3519 3522 3485 3488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef</italic>
###xml 3680 3682 3636 3638 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 3791 3793 3747 3749 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 3808 3810 3764 3766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 3978 3980 3934 3936 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 4000 4002 3956 3958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6C</xref>
###xml 4007 4009 3963 3965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6D</xref>
###xml 4096 4100 4048 4052 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 4203 4206 4145 4148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef</italic>
###xml 4532 4534 4464 4466 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 79 84 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 953 958 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 984 989 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1001 1006 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1655 1660 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1973 1978 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2289 2292 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 2636 2639 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 3200 3203 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 3302 3307 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 3699 3702 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 3733 3736 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 4027 4032 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 4551 4556 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
To further analyze how Nef accelerates depletion of CD4+ T lymphocytes in HLAC HIV-1 infection, we sought to determine whether Nef primarily affects the killing of productively infected or uninfected (bystander) CD4+ T cells. Since reproducible analyses of specific markers for apoptosis such as active caspase 3 or cell surface annexinV in combination with the fixation method and intracellular stain for p24 proved difficult in our experimental system (data not shown), we analyzed cell death by staining with 7AAD, a nucleic acid dye that binds to genomic DNA of dead, necrotic and late apoptotic cells because of their increased membrane permeability. For analysis, we gated on CD4+ T lymphocytes to determine their 7AAD incorporation and intracellular p24 expression (see Methods for details). Control experiments ensured that the 7AAD staining was stable during the fixation and permeabilization procedures (data not shown). The infection with wt HIV-1 was compared to Deltanef HIV-1 as well as HIV-1 coding for the Nef LLAA or Delta12-39 variants, the two mutants that displayed defects in CD4+ T lymphocyte depletion in the above analyses. Fig. 5 shows primary data of such an analysis for one donor. As before, CD4+ T lymphocytes were identified as CD3+/CD8- population, carefully avoiding autofluorescent cells in the center of the dot plot (Fig. 5A). When these CD4+ T lymphocytes were analyzed for the expression of p24 and staining for 7AAD (Fig. 5B), the mock-infected culture, expectedly, only showed background staining for p24. On day 8 p.i., 27.1% of all CD4+ T lymphocytes stained positive for 7AAD and were thus considered dead. In wt HIV-1-infected cultures, a population of p24-positive viable CD4+ T lymphocytes was readily detectable (10.9%, upper left quadrant). A small fraction of p24-positive cells also stained positive for 7AAD (1.7% of all CD4+ T lymphocytes; 13.7% of all p24+ CD4+T lymphocytes; upper right quadrant) (Fig. 5D). Notably, wt HIV-1 infection increased the number of 7AAD+/p24- cells (33.2% of all CD4+ T lymphocytes; 38.0% of all p24- CD4+ T lymphocytes; lower right quadrant), reflecting bystander killing in response to virus infection (Fig. 5E). This increase in death of p24- bystander cells was less pronounced in cultures infected with HIV-1Deltanef (19.8% of all CD4+ T lymphocytes; 21.1% of all p24- CD4+ T lymphocytes). Plotting of the total number of productively infected CD4+ T lymphocytes revealed slightly fewer infected cells in cultures infected with the Deltanef relative to the wt virus (Fig. 5C). Interpretation of these results was complicated by the varying degree of HIV-unrelated cell death between HLAC replicates, but also HLAC cultures from different donors. To account for this, analysis of quadruplicate infections of HLAC from five different donors was performed to quantify and statistically evaluate this effect (Fig. 6). First, total amounts of p24+ cells present in these cultures (irrespective of their sensitivity to staining with 7AAD) (Fig. 6A) were significantly increased in the presence of Nef (wt: 17.7 +/- 0.8% vs Deltanef: 8.6 +/- 0.7%, p = 0.0079). Nef thus expands the pool of productively infected cells in HIV HLAC infections. Although the 7AAD staining appeared slightly increased in cells infected with wt HIV-1 relative to Deltanef or the two Nef mutants (Fig. 6B, data expressed as percentage relative to wt that was arbitrarily set to 100%), these differences were not statistically significant (wt: 100 +/- 15.2%; Deltanef: 65.1 +/- 11.7%; LLAA: 81.6 +/- 6.3%; Delta12-39: 74.9 +/- 11.0%). This indicated that Nef does not have major pro- or anti-apoptotic effects on infected CD4+ T lymphocytes in HIV-infected HLAC. However, since HIV infection clearly reduces the overall life span of CD4+ T lymphocytes [41], the fact that Nef expands the target cell population will indirectly contribute to T cell depletion in HLAC. In contrast, significantly more killing of bystander CD4+ T lymphocytes (Fig. 6C and 6D) was observed in HIV-1 wt-infected cultures when compared to infections with the Deltanef or the LLAA and Delta12-39 Nef mutant viruses [wt: 154.6 +/- 34.2% (p = 0.0079 compared to mock); Deltanef: 92.8 +/- 6.5% p = 0.0317; LLAA: 107 +/- 5.3% p = 0.0556; Delta12-39: 99.7 +/- 5.9% p = 0.0159, data expressed as percentage relative to mock that was arbitrarily set to 100%]. These results identify the interaction motifs for endocytic machinery and the NAKC signalosome as key determinants for Nef-mediated depletion of CD4+ T lymphocytes in HIV-1 HLAC infections and suggest that Nef selectively augments the efficacy of bystander killing.
###end p 23
###begin p 24
###xml 0 45 0 45 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Analysis of cell death in HIV-1-infected HLAC</bold>
###xml 94 103 94 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#916;nef </italic>
###xml 400 401 392 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 405 407 397 399 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 538 540 530 532 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 613 614 605 606 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 619 621 611 613 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 695 696 687 688 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 715 716 707 708 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 721 723 713 715 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 799 800 791 792 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 817 818 809 810 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 823 825 815 817 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 915 917 907 909 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 26 31 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 87 92 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 103 108 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 511 516 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Analysis of cell death in HIV-1-infected HLAC. HLACs were infected with 6 ng p24 of wt HIV-1, Deltanef HIV-1 and the two Nef variants LLAA and Delta12-39 in quadruplicates. On day 8 p.i., cells were stained for 7AAD, CD3, CD8 and intracellular p24. Results from one single infection are shown. (A) Flow cytometry analysis of the CD3/CD8 stain of live T lymphocytes. (B) Flow cytometry analysis of CD3+/CD8- lymphocytes (based on the gating in A) for intracellular p24 and 7AAD for the detection of productively HIV-1 infected and dead CD4+ T cells, respectively, (C) Percentage of total productively infected (p24+) CD4+ lymphocytes in the HLAC infection shown in A. (D) Percentage of dead (7AAD+) and infected (p24+) CD4+ T lymphocytes in the HLAC infection shown in A. (E) Percentage of dead (7AAD+) uninfected (p24-) CD4+ T lymphocytes in the HLAC infection shown in A. Mock designates the percentage of dead CD4+ T lymphocytes in the mock-infected culture.
###end p 24
###begin p 25
###xml 0 56 0 56 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Nef augments bystander T cell death in HIV-infected HLAC</bold>
###xml 233 235 233 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 294 296 294 296 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 399 401 399 401 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 39 42 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Nef augments bystander T cell death in HIV-infected HLAC. Summary of cell death analysis in HLAC infections as described in Fig. 5 from quadruplicate infections of HLAC from 5 donors. (A) Percentage of total productively infected CD4+ T lymphocytes. (B) Percentage of 7AAD-positive infected CD4+ T lymphocytes relative to wt that was arbitrarily set to 100%. (C, D) Percentage of dead uninfected CD4+ T lymphocytes relative to mock controls that were arbitrarily set to 100%. C depicts individual data points with the colour code identifying separate experiments, D the mean and SEM of these experiments. p-values indicate statistical significance based on Mann-Whitney-U analysis.
###end p 25
###begin title 26
Discussion
###end title 26
###begin p 27
###xml 101 103 101 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 120 127 120 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo</italic>
###xml 207 211 203 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 325 327 321 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 362 364 358 360 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 525 529 517 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 916 918 908 910 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 63 68 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 150 155 <span type="species:ncbi:9606">human</span>
###xml 211 216 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 307 310 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 780 785 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
This study aimed at the characterization of the role of Nef in HIV-1 replication and depletion of CD4+ T lymphocytes in ex vivo-aggregate cultures of human tonsil tissue. Extensive comparison of wt and Deltanef HIV-1 in HLAC from a large number of donors demonstrated that Nef elevates the efficacy of both HIV spread and CD4+ T lymphocyte depletion. Loss of CD4+ T lymphocytes apparently occurred predominantly in uninfected bystander cells and was more pronounced in the presence of Nef even in scenarios where wt and Deltanef viruses displayed comparable replication kinetics and p24 production. A panel of isogenic Nef mutant viruses consistently revealed a partial segregation of Nef activities: while a large number of molecular determinants in Nef was required for optimal HIV-1 spread in HLAC, two distinct protein interaction surfaces were identified that specifically govern Nef-mediated enhancement of CD4+ T lymphocyte depletion which preferentially occurs in bystander cells.
###end p 27
###begin p 28
###xml 113 114 113 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 115 117 115 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 131 134 131 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef</italic>
###xml 212 215 212 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef</italic>
###xml 380 387 380 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo</italic>
###xml 538 540 538 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 578 585 578 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo</italic>
###xml 673 681 673 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 682 684 682 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 766 774 766 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo </italic>
###xml 821 828 821 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1051 1053 1051 1053 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1176 1183 1176 1183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1240 1247 1240 1247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo</italic>
###xml 80 85 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 362 367 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 424 429 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 744 747 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 929 934 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1087 1092 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1110 1113 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The results presented confirm and extend the previously observed enhancement of HIV-1 replication in HLH by Nef [8,36]. Typically, nef-positive viruses grow with faster kinetics and higher peak titers than their nef-negative isogenic counterparts. In line with earlier work, these results establish HLAC as a relatively robust assay system for effects of Nef on HIV-1 replication ex vivo. However, the magnitude of elevated HIV-1 spread observed in the presence of Nef is not markedly more pronounced than that obtained in PBMC cultures [27]. The overall effects of Nef in this ex vivo-cell system are significantly lower than the 2-3 log increase in virus titers reported in vivo [18]. This may, in part, reflect the lack of a CTL response to HIV-infected cells in ex vivo model systems, which is potently evaded by Nef in vivo, the relatively short time frame of the experiments as well as the use of a lab-adapted CXCR4 using HIV-1 strain. In contrast to PBMC cultures, however, HLAC allows a concurrent and prospective experimental analysis of CD4+ T lymphocyte depletion induced by HIV-1 infection. Thus, HIV-infected HLAC recapitulates some of the key activities of Nef in vivo, but the magnitude of the effects is attenuated in this ex vivo-primary cell culture system.
###end p 28
###begin p 29
###xml 133 135 133 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 331 333 331 333 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 536 537 536 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 917 919 917 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 920 922 920 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 459 464 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 692 697 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1007 1012 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Although we cannot fully exclude that Nef expression leads to elevated intracellular p24 levels, the fact that significantly less p24+ cells are present in the absence of Nef suggests that the lack of Nef limits the infection of new target cells rather than affecting the amounts of particles produced per productively infected CD4+ T lymphocyte. This would be in line with conclusions reached by Glushakova et al. that reported comparable levels of per cell HIV-1 gene expression in HLAC infections in the presence and absence of Nef [8]. Our analysis of specific molecular Nef determinants revealed a complex scenario in which each Nef mutant individually caused a reduction of p24 levels (HIV-1 production and spread) relative to the wt protein. While the precise effector functions of these individual protein surfaces in HLAC remain unclear, these results suggest that, similar to the scenario in PBMC cultures [27,42], several independent Nef activities are necessary, but not sufficient, for optimal HIV-1 replication.
###end p 29
###begin p 30
###xml 53 62 53 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#916;nef </italic>
###xml 213 214 209 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 492 500 488 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo </italic>
###xml 883 886 879 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef</italic>
###xml 1015 1017 1011 1013 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 62 67 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 479 484 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 683 688 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 760 765 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 895 900 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1138 1143 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1272 1277 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1737 1742 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Of note, comparison of p24 production between wt and Deltanef HIV-1 in HLAC revealed comparable growth of both viruses in approximately one half of the experiments, while Nef promoted overall p24 production (Fig. 3) and replication kinetics (data not shown) in the other half of the experiments. As such divergent results were also obtained with identical virus stocks, they most likely reflect different properties of HLAC from different donors, suggesting that Nef's effect on HIV-1 spread ex vivo can be context-dependent. Similar replication kinetics of both viruses could in principle reflect a loss of Nef function or a circumvention for the need for Nef in these cells. Since HIV-1 replication in these cultures reached levels typically observed for wt HIV-1 in HLAC from other donors, we conclude that these target cells are preconditioned to support the efficient spread of nef-deleted HIV-1. An obvious difference between HLAC from individual donors may be the intrinsic activation state of the target CD4+ T lymphocytes. However, extensive analysis of T cell activation markers including CD25, CD69 and HLA-DR prior and during HIV-1 infection failed to reveal any correlation between the expression of these markers and detection of a Nef-dependent increase of HIV-1 replication (data not shown). We also failed to observe major differences in surface levels of the entry coreceptor CXCR4 in mock infected HLAC from different donors, suggesting that the observed donor variability does not reflect altered permissivity for infection of these cultures due to changes in entry coreceptor cell surface exposure (data not shown). The identification of host cell conditions that desensitize cells for the Nef-mediated elevation of HIV-1 replication efficiency will be an important aim of future studies.
###end p 30
###begin p 31
###xml 102 104 102 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 107 109 107 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 334 336 334 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 337 339 337 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 572 577 572 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 580 582 580 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 758 760 758 760 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 871 873 871 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1433 1435 1433 1435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1765 1767 1765 1767 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 85 88 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 174 177 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 436 441 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 674 679 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 777 782 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1601 1606 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Importantly, we failed to detect significant effects of Nef on the frequency of dead HIV-infected, p24+ CD4+ T lymphocytes in HLAC, a primary cell model that displays robust HIV-mediated cytotoxicity. This was somewhat surprising given that Nef expression has been reported to cause both pro- as well as anti-apoptotic effects (e.g. [43-49]). However, most of these studies were performed in cell line overexpression systems instead of HIV-1 infected primary cells and did not involve analyses of HLAC cultures. Rather, our results agree with a recent report by Schindler et al. [50], in which no effect of Nef on apoptosis triggered by a variety of stimuli was observed in HIV-1-infected PBMC cultures. Jekle and colleagues established that depletion of CD4+ T lymphocytes by HIV-1 infection in HLAC predominantly results from the killing of uninfected bystander cells [17]. Our attempts to verify these findings were complicated by the fact that the intracellular p24 staining procedure used most likely fails to sensitively detect infection of late apoptotic and thus proteolytic active cells, and 7AAD does not efficiently score for cells early in apoptosis with intact membranes. These technical limitations, however, equally apply to cells infected with all the viruses compared in this study; and the frequency of cell death in infected and bystander cells detected closely matched that of apoptotic cells detected by others [17]. Although populations of apoptotic and/or productively infected cells might have been missed, our results revealed a substantial amount of dead uninfected cells in HIV-1 infected HLAC, the proportion of which was increased in the presence of Nef. Collectively, our results therefore suggest that the Nef-mediated increase of CD4+ T lymphocyte depletion predominately stems from the elevated death of p24-negative bystander cells.
###end p 31
###begin p 32
###xml 78 80 78 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 334 336 334 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 489 491 489 491 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 848 850 848 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 851 853 851 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 887 889 887 889 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1128 1130 1128 1130 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1238 1240 1238 1240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 1241 1243 1241 1243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 1249 1257 1249 1257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo </italic>
###xml 1526 1528 1526 1528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 1529 1531 1529 1531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 1708 1710 1708 1710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 1792 1794 1792 1794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 1795 1797 1795 1797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 745 750 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1151 1154 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
The mapping of molecular determinants that govern Nef-mediated increase in CD4+ T lymphocyte death identified the C-terminal di-leucine motif and the interaction site for the NAKC signalosome as two distinct protein interaction sites involved in this process. Individual mutation of both motifs significantly impaired Nef-mediated CD4+ T lymphocyte depletion, indicating that both motifs are critical for this activity. Surprisingly, non-myristoylated Nef (G2A) retained wt activity in CD4+ T lymphocyte depletion, although membrane association via its myristoylated N-terminus is thought to be vital for virtually all Nef activities. However, membrane association and biological activity such as CD4 downregulation of the Nef allele used here (HIV-1 SF2) is only partially impaired by the G2A mutation due to additional membrane targeting motifs [27,37], indicating that Nef induced CD4+ T lymphocyte depletion can occur in the absence of myristoylation and thus only requires moderate membrane affinity. Analysis of the AxxA Nef mutant also revealed that interactions with SH3 domain containing ligands are dispensable for CD4+ T cell depletion. In SIV-infected macaques, the relevance of the SH3-binding motif in Nef is controversial [51-53]. In ex vivo studies, however, this Nef protein interaction surface affects receptor transport (e.g. downregulation of cell surface MHC-I) as well as cell activation events (e.g. association with PAK2 kinase activity), two processes that do not correlate with Nef activity in HLAC [36,54]. This is well in line with the observed wt activities of the Nef E4A4 and KKAA mutants that are disrupted in the interaction site for PACS (involved in MHC-I downmodulation, [55]) and targeting to plasma membrane microdomains (where Nef associates with PAK2 [37,56]).
###end p 32
###begin p 33
###xml 52 54 52 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 248 250 248 250 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 481 483 481 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 850 854 846 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 1505 1507 1501 1503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 1508 1510 1504 1506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 1774 1776 1770 1772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 1902 1904 1898 1900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 1905 1907 1901 1903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 2299 2301 2295 2297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
###xml 2399 2401 2395 2397 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 2526 2527 2522 2523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 2528 2530 2524 2526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 2655 2657 2651 2653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B63">63</xref>
###xml 2658 2660 2654 2656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B64">64</xref>
###xml 2818 2826 2814 2822 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo </italic>
###xml 2867 2874 2863 2870 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 2950 2952 2946 2948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B64">64</xref>
###xml 267 272 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 854 859 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1393 1396 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 2158 2163 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2691 2694 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 2704 2719 <span type="species:ncbi:9531">sooty mangabeys</span>
###xml 2882 2887 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
As mentioned above, we favor a scenario in which CD4+ T lymphocyte depletion occurs predominately in uninfected bystander cells. The results presented allow us to speculate by which mechanism Nef might stimulate this process. Death of bystander CD4+ T lymphoyctes in HIV-1 infected HLAC is induced by the shedding of Env glycoprotein from infected cells and the subsequent triggering of cell death programs upon interaction of soluble Env with CXCR4 on uninfected bystander cells [17]. Similarly, cell death could be triggered by cell-associated Env via direct contacts with neighboring cells. As a consequence of both mechanisms, the number of infected cells is one determining parameter for the efficacy of bystander apoptosis in the culture. One simple reason for the elevated levels of bystander cell death in infections with wt relative to Deltanef HIV-1 can thus be attributed to the larger pool of productively infected cells. However, the observed increase in bystander cell death in the absence of elevated replication levels in some HLACs together with the identification of molecular determinants that specifically govern Nef-mediated bystander killing suggest that Nef also exerts more direct effects. In one possible scenario, Nef promotes shedding of Env and subsequent bystander killing. In fact, by reducing tethering of Env to the primary entry receptor CD4 at the surface of HIV-producing cells, downmodulation of cell surface CD4 by Nef increases the levels of Env in released virions [57-59]. Via the same mechanism, Nef might facilitate shedding of Env from the cell surface, an activity that would be hampered by disruption of CD4 downmodulation via the LLAA mutation. Nef also promotes plasma membrane exposure of Env via a CD4-independent mechanism [60], an effect that may well be supported by enhanced transcriptional activity of the viral genome due to the assembly of NAKC [39,40]. Thus, both identified determinants for Nef-mediated bystander killing could synergize to maximum cell surface presentation and shedding of Env which is prone to trigger bystander killing. Although only tested herein in the context of a CXCR4 using HIV-1 strain, Nef generally exerts its activities with comparable efficiency in the context of viruses that use CCR5 as an entry coreceptor [61]. However, the cytotoxicity of CCR5 tropic Env proteins is relatively reduced, explaining why CD4+ T lymphocyte depletion is generally mild and can only be slightly enhanced by Nef in HLAC infections with R5-tropic strains [9,62]. Finally, Nef was recently implicated in the cell surface regulation of the program death receptor PD-1 in infected cells [63,64]. Analyzing Nef variants from SIV infected sooty mangabeys, Schindler and colleagues could correlate the potency by which Nef prevents PD-1 surface exposure ex vivo with low levels of CD4 T lymphocyte loss in vivo, while HIV-1 Nef variants failed to downregulate cell surface PD-1 levels [64]. As PD-1 can induce death in bystander cells expressing PD-1 ligands, it will be of interest to analyze the role of PD-1 in Nef-mediated bystander cell death in HLH infections.
###end p 33
###begin title 34
Conclusion
###end title 34
###begin p 35
###xml 95 97 95 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 479 486 479 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo</italic>
###xml 523 528 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 644 652 <span type="species:ncbi:9606">patients</span>
Together, this analysis of Nef function in HLAC revealed that Nef promotes the depletion of CD4+ T lymphocytes by two mechanisms. First, Nef expands the pool of productively infected cells, thereby elevating net levels of cell killing. Second, Nef increases the intrinsic potential of such productively infected cells to trigger killing, presumably most prominently in uninfected bystander cells. These results underscore the usefulness of HLAC as an experimental system for the ex vivo-analysis of pathogenic processes in HIV-1 infection and suggest that triggered bystander killing may contribute to Nef's pathological properties in infected patients.
###end p 35
###begin title 36
Methods
###end title 36
###begin title 37
Virus constructs and stocks
###end title 37
###begin p 38
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 107 109 107 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 121 125 121 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 203 207 203 207 <sub xmlns:xlink="http://www.w3.org/1999/xlink">SF2 </sub>
###xml 283 289 283 289 <sub xmlns:xlink="http://www.w3.org/1999/xlink">NL4-3 </sub>
###xml 320 323 320 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef</italic>
###xml 468 470 468 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 471 473 471 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 576 578 576 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B65">65</xref>
###xml 781 783 781 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
###xml 198 201 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 278 281 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 438 443 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 532 535 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 651 656 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
All proviral plasmids used here were previously described and the expressed Nef variants characterized [27,37]. Briefly, nef genes and thus also the overlapping U3 enhancer/promoter region from the HIV-1SF2 (wild-type or carrying the indicated mutations) were inserted into the HIV-1NL4-3 proviral DNA and compared to a nef-deleted variant entirely lacking Nef expression. All Nef variants analyzed herein express to comparable levels in HIV-1 infected T lymphocytes [27,37]. Virus stocks were generated by transfection of proviral HIV plasmids into 293 T cells as described [65]. Two days after transfection, culture supernatants were harvested. The HIV-1 p24 antigen concentration of concentrated stocks was determined by a p24 antigen enzyme-linked immunosorbent assay (ELISA) [66].
###end p 38
###begin title 39
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human Lymphoid Aggregate Culture (HLAC) from tonsil
###end title 39
###begin p 40
###xml 319 321 318 320 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 727 729 725 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 730 732 728 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 826 828 824 826 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 60 63 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 66 69 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 72 75 <span type="species:ncbi:11103?0.9633797444211329|species:ncbi:11096?0.008773602899103566">HCV</span>
###xml 85 93 <span type="species:ncbi:9606">patients</span>
###xml 480 486 <span type="species:ncbi:9913">bovine</span>
###xml 798 803 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Tonsil tissue was removed during routine tonsillectomy from HIV-, HBV-, HCV-negative patients with informed consent. To prepare HLAC, tonsil tissue was mechanically dispersed by cutting tissue in 2- to 3-mm blocks and passing them through 40-mum cell strainers (BD Falcon, Belgium). Cells were washed in PBS, and 2 x 106 cells were plated in 96-well V-bottom plates (Corning Incorporated, New York, NY) in a final volume of 200 mul. Culture medium (RPMI 1640 containing 15% fetal bovine serum, 1% L-glutamine, 1% fungizone, 1% gentamycin (all from GIBCO), 0.25% ampicillin (Roth, Karlsruhe, Germany), 1% non-essential amino acids, and 1% sodium pyruvat (both from Invitrogen)). Detailed cultivation methods have been reported [12,17]. One day after tonsil preparation, the HLAC was inoculated with HIV-1 (3-6 ng p24 per 2 x 106 cells per well). Following overnight infection cells were washed and the culture medium was subsequently changed every three days without dispersing the pellet. At the same time intervals supernatant samples were harvested and stored at -20degreesC for subsequent analysis by p24 ELISA.
###end p 40
###begin title 41
###xml 22 24 22 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
Flow cytometry for CD4+ T lymphocyte depletion and cell death analysis
###end title 41
###begin p 42
###xml 130 132 130 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 425 427 425 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 433 435 433 435 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 477 478 477 478 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 482 484 482 484 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 566 568 566 568 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 242 247 <span type="species:ncbi:9606">human</span>
###xml 292 297 <span type="species:ncbi:9606">human</span>
###xml 533 536 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 617 622 <span type="species:ncbi:9606">human</span>
###xml 669 674 <span type="species:ncbi:9606">human</span>
All flow cytometry was performed with a FACS Calibur with BD CellQuest Pro 4.0.2 Software (BD Pharmingen). For the analysis of CD4+ T lymphocyte depletion, cells were stained with the following antibodies without prior permeabilization: anti-human CD3 FITC (clone HIT3a, BD Pharmingen), anti-human CD8 APC (clone RPA-T8, BD Pharmingen) and subsequently fixed (1.5 hrs, 2% paraformaldehyde). Using standard gating procedures [17], CD4+ T lymphocytes were then defined as the CD3+/CD8- lymphocyte population. To determine the death of HIV-infected and non-infected CD4+ T lymphocytes, cells were first stained for anti-human CD3 APC (clone HIT3a, BD Pharmingen) and anti-human CD8 PE (clone RPA-T8, BD Pharmingen) and 7AAD (2.5 mug/ml) (BD Pharmingen) as described above. Following subsequent fixation cells were permeabilized in PBS with 0.1% Triton X-100 and simultaneously stained for intracellular p24 using anti-p24 antibody KC57 FITC (Beckman Coulter, Fullerton, CA) 20 min at RT.
###end p 42
###begin title 43
Statistical analysis
###end title 43
###begin p 44
Analysis of HLAC infections was carried out in independent quadruplicate infections for each time point investigated. Mean values and standard deviation were calculated from these quadruplicates. For comparison of individual HLAC infections, mean values of each data set were averaged with the indicated standard error of the mean. For evaluation of statistical significance, data sets were first analyzed for normal distribution by the Kolmogorov-Smirnow test. As this test for Normality failed for some populations, the non-parametric Mann-Whitney-U analysis was employed throughout (***, P </= 0.0005; **, P < 0.005; *, P < 0.05). GraphPad Prism software (GraphPad Software Inc.) was used for all statistical analyses.
###end p 44
###begin p 45
###xml 23 25 23 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 59 61 59 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 67 69 67 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 262 264 262 264 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 270 272 270 272 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 697 699 697 699 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 731 733 731 733 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 805 806 805 806 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 811 812 811 812 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 842 843 842 843 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 848 849 848 849 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 879 880 879 880 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 885 886 885 886 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 917 918 917 918 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 923 924 923 924 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
For the analysis of CD4+ T cell depletion, the ratio of CD4+ to CD8+ T lymphocytes was determined and expressed relative to the uninfected control whose ratio was arbitrarily set to 100%. Depletion efficiencies were calculated relative to this value with the CD4+ to CD8+ ratio of uninfected cultures considered as 0% depletion. For quantification of virus replication, p24 concentrations of individual infections were plotted over the course of the experiment. To account best for rapid changes in p24 concentration, the integral area under the curve (AUC) was determined and used as measure of overall p24 production. To determine the percentage of killed infected and non-infected bystander CD4+ T cells, four populations of CD4+ T lymphocytes were defined and quantified: uninfected, living cells (p24-/7AAD-), uninfected, dead cells (p24-/7AAD+), infected, living cells (p24+/7AAD-) and infected, dead cells (p24+/7AAD+).
###end p 45
###begin title 46
Competing interests
###end title 46
###begin p 47
The authors declare that they have no competing interests.
###end p 47
###begin title 48
Authors' contributions
###end title 48
###begin p 49
SH and NT performed the experimental work. OTK and OTF conceived the experimental strategies and SH, OTK and OTF designed individual experiments. IB and SS provided tonsillectomy material. SH, OTK and OTF analyzed the data and OTF wrote the manuscript.
###end p 49
###begin title 50
Supplementary Material
###end title 50
###begin title 51
Additional File 1
###end title 51
###begin p 52
###xml 0 25 0 25 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Supplementary figure one.</bold>
###xml 208 209 208 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 213 215 213 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 109 114 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Supplementary figure one. Direct staining of CD4 was avoided due to the reduction of CD4 surface exposure in HIV-1 infected cells, but a control staining for mock infected cells reveals that virtually all CD3+/CD8- cells in this gate were positive for CD4.
###end p 52
###begin p 53
Click here for file
###end p 53
###begin title 54
Acknowledgements
###end title 54
###begin p 55
The authors thank Dr. Lars Kaderali for expert advice on statistical evaluation and Stephanie Venzke and Silvia Geuenich for help with the HLAC set up. This work was supported by the Deutsche Forschungsgemeinschaft (SFB 638, project A11 to OTF; SFB 544, project B17 to OTK).
###end p 55
###begin article-title 56
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 pathogenesis
###end article-title 56
###begin article-title 57
###xml 41 44 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The dynamics of CD4+ T-cell depletion in HIV disease
###end article-title 57
###begin article-title 58
###xml 25 28 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
CD4+ T-cell depletion in HIV infection: are we closer to understanding the cause?
###end article-title 58
###begin article-title 59
###xml 92 95 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 101 104 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes
###end article-title 59
###begin article-title 60
###xml 13 18 <span type="species:ncbi:9606">human</span>
###xml 53 56 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Infection of human tonsil histocultures: a model for HIV pathogenesis
###end article-title 60
###begin article-title 61
###xml 13 16 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 30 35 <span type="species:ncbi:9606">human</span>
###xml 208 215 <span type="species:ncbi:9606">patient</span>
###xml 228 231 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Experimental HIV infection of human lymphoid tissue: correlation of CD4+ T cell depletion and virus syncytium-inducing/non-syncytium-inducing phenotype in histocultures inoculated with laboratory strains and patient isolates of HIV type 1
###end article-title 61
###begin article-title 62
###xml 17 22 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Evidence for the HIV-1 phenotype switch as a causal factor in acquired immunodeficiency
###end article-title 62
###begin article-title 63
###xml 13 41 <span type="species:ncbi:12721">human immunodeficiency virus</span>
###xml 93 98 <span type="species:ncbi:9606">human</span>
Nef enhances human immunodeficiency virus replication and responsiveness to interleukin-2 in human lymphoid tissue ex vivo
###end article-title 63
###begin article-title 64
###xml 68 73 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 83 88 <span type="species:ncbi:9606">human</span>
CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissue
###end article-title 64
###begin article-title 65
###xml 17 52 <span type="species:ncbi:11709">human immunodeficiency virus type 2</span>
###xml 54 59 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 64 69 <span type="species:ncbi:9606">human</span>
###xml 136 141 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Cytopathicity of human immunodeficiency virus type 2 (HIV-2) in human lymphoid tissue is coreceptor dependent and comparable to that of HIV-1
###end article-title 65
###begin article-title 66
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 does not provoke alteration of cytokine gene expression in lymphoid tissue after acute infection ex vivo
###end article-title 66
###begin article-title 67
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 66 71 <span type="species:ncbi:9606">human</span>
HIV-1 actively replicates in naive CD4(+) T cells residing within human lymphoid tissues
###end article-title 67
###begin article-title 68
###xml 5 8 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Anti-HIV state but not apoptosis depends on IFN signature in CD4+ T cells
###end article-title 68
###begin article-title 69
###xml 65 68 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
TLR7/8 triggering exerts opposing effects in acute versus latent HIV infection
###end article-title 69
###begin article-title 70
###xml 40 75 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 117 122 <span type="species:ncbi:9606">human</span>
Vpr and Vpu are important for efficient human immunodeficiency virus type 1 replication and CD4+ T-cell depletion in human lymphoid tissue ex vivo
###end article-title 70
###begin article-title 71
###xml 88 123 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Tissue-resident macrophages are productively infected ex vivo by primary X4 isolates of human immunodeficiency virus type 1
###end article-title 71
###begin article-title 72
###xml 21 56 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
In vivo evolution of human immunodeficiency virus type 1 toward increased pathogenicity through CXCR4-mediated killing of uninfected CD4 T cells
###end article-title 72
###begin article-title 73
Importance of the nef gene for maintenance of high virus loads and for development of AIDS
###end article-title 73
###begin article-title 74
###xml 52 57 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients
###end article-title 74
###begin article-title 75
###xml 90 95 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection
###end article-title 75
###begin article-title 76
###xml 60 65 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo
###end article-title 76
###begin article-title 77
###xml 85 90 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 94 109 <span type="species:ncbi:10090">transgenic mice</span>
Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice
###end article-title 77
###begin article-title 78
###xml 50 55 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Modulation of the immunological synapse: a key to HIV-1 pathogenesis?
###end article-title 78
###begin article-title 79
###xml 36 41 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Structure-function relationships in HIV-1 Nef
###end article-title 79
###begin article-title 80
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 Nef: adapting to intracellular trafficking pathways
###end article-title 80
###begin article-title 81
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Nef: at the crossroads
###end article-title 81
###begin article-title 82
###xml 31 36 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Functional characterization of HIV-1 Nef mutants in the context of viral infection
###end article-title 82
###begin article-title 83
###xml 4 9 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The HIV-1 nef gene acts as a positive viral infectivity factor
###end article-title 83
###begin article-title 84
###xml 42 77 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes
###end article-title 84
###begin article-title 85
###xml 24 59 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Virion incorporation of human immunodeficiency virus type 1 Nef is mediated by a bipartite membrane-targeting signal: analysis of its role in enhancement of viral infectivity
###end article-title 85
###begin article-title 86
###xml 26 31 <span type="species:ncbi:9606">Human</span>
Endothelial cells promote Human Immunodeficiency Virus replication in nondividing memory T cells via Nef-, Vpr-, and T-Cell Receptor-dependent activation of NFAT
###end article-title 86
###begin article-title 87
###xml 65 70 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A natural variability in the proline-rich motif of Nef modulates HIV-1 replication in primary T cells
###end article-title 87
###begin article-title 88
###xml 38 67 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
The decreased replicative capacity of simian immunodeficiency virus SIVmac239Delta(nef) is manifest in cultures of immature dendritic cellsand T cells
###end article-title 88
###begin article-title 89
###xml 30 35 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Nef is required for efficient HIV-1 replication in cocultures of dendritic cells and lymphocytes
###end article-title 89
###begin article-title 90
Nef-mediated enhancement of virion infectivity and stimulation of viral replication are fundamental properties of primate lentiviruses
###end article-title 90
###begin article-title 91
###xml 23 58 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 151 156 <span type="species:ncbi:9606">human</span>
CD4 down-modulation by human immunodeficiency virus type 1 Nef correlates with the efficiency of viral replication and with CD4(+) T-cell depletion in human lymphoid tissue ex vivo
###end article-title 91
###begin article-title 92
###xml 92 97 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Specific and distinct determinants mediate membrane binding and lipid raft incorporation of HIV-1(SF2) Nef
###end article-title 92
###begin article-title 93
Mechanisms of CD4 downregulation by the Nef and Vpu proteins of primate immunodeficiency viruses
###end article-title 93
###begin article-title 94
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Nef mimics an integrin receptor signal that recruits the polycomb group protein Eed to the plasma membrane
###end article-title 94
###begin article-title 95
###xml 53 56 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Novel (n)PKC kinases phosphorylate Nef for increased HIV transcription, replication and perinuclear targeting
###end article-title 95
###begin article-title 96
###xml 0 28 <span type="species:ncbi:12721">Human immunodeficiency virus</span>
###xml 30 33 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Human immunodeficiency virus (HIV)-1 proteins and cytoskeleton: partners in viral life and host cell death
###end article-title 96
###begin article-title 97
###xml 44 79 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Nef-mediated downregulation of CD4 enhances human immunodeficiency virus type 1 replication in primary T lymphocytes
###end article-title 97
###begin article-title 98
###xml 38 41 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor zeta chain
###end article-title 98
###begin article-title 99
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Nef associated PAK and PI3-kinases stimulate Akt-independent Bad-phosphorylation to induce anti-apoptotic signals
###end article-title 99
###begin article-title 100
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell
###end article-title 100
###begin article-title 101
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 Nef protein sensitizes CD4(+) T lymphoid cells to apoptosis via functional upregulation of the CD95/CD95 ligand pathway
###end article-title 101
###begin article-title 102
Extracellular Nef protein targets CD4+ T cells for apoptosis by interacting with CXCR4 surface receptors
###end article-title 102
###begin article-title 103
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 78 83 <span type="species:ncbi:9606">human</span>
Human Immunodeficiency virus type 1 Nef potently induces apoptosis in primary human brain microvascular endothelial cells via the activation of caspases
###end article-title 103
###begin article-title 104
###xml 75 110 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Commitment to apoptosis in CD4(+) T lymphocytes productively infected with human immunodeficiency virus type 1 is initiated by lysosomal membrane permeabilization, itself induced by the isolated expression of the viral protein Nef
###end article-title 104
###begin article-title 105
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 inhibits DNA damage-triggered apoptosis by a Nef-independent mechanism
###end article-title 105
###begin article-title 106
###xml 21 24 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 29 32 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 61 76 <span type="species:ncbi:9544">rhesus macaques</span>
Activation of PAK by HIV and SIV Nef: importance for AIDS in rhesus macaques
###end article-title 106
###begin article-title 107
###xml 33 62 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
###xml 128 143 <span type="species:ncbi:9544">rhesus macaques</span>
Role of the SH3-ligand domain of simian immunodeficiency virus Nef in interaction with Nef-associated kinase and simian AIDS in rhesus macaques
###end article-title 107
###begin article-title 108
###xml 15 44 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
###xml 134 149 <span type="species:ncbi:9544">rhesus macaques</span>
Association of simian immunodeficiency virus Nef with cellular serine/threonine kinases is dispensable for the development of AIDS in rhesus macaques
###end article-title 108
###begin article-title 109
###xml 76 111 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 162 167 <span type="species:ncbi:9606">human</span>
Association of Nef with p21-activated kinase 2 is dispensable for efficient human immunodeficiency virus type 1 replication and cytopathicity in ex vivo-infected human lymphoid tissue
###end article-title 109
###begin article-title 110
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Nef protein binds to the cellular protein PACS-1 to downregulate class I major histocompatibility complexes
###end article-title 110
###begin article-title 111
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 Nef recruits the guanine exchange factor Vav1 via an unexpected interface into plasma membrane microdomains for association with p21-activated kinase 2 activity
###end article-title 111
###begin article-title 112
###xml 19 24 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Endocytic entry of HIV-1
###end article-title 112
###begin article-title 113
###xml 39 44 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner
###end article-title 113
###begin article-title 114
###xml 15 50 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Nef stimulates human immunodeficiency virus type 1 replication in primary T cells by enhancing virion-associated gp120 levels: coreceptor-dependent requirement for Nef in viral replication
###end article-title 114
###begin article-title 115
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 128 133 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Nef enhances both membrane expression and virion incorporation of Env products. A model for the Nef-dependent increase of HIV-1 infectivity
###end article-title 115
###begin article-title 116
###xml 13 48 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Nef enhances human immunodeficiency virus type 1 infectivity and replication independently of viral coreceptor tropism
###end article-title 116
###begin article-title 117
###xml 32 60 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Coreceptor phenotype of natural human immunodeficiency virus with nef deleted evolves in vivo, leading to increased virulence
###end article-title 117
###begin article-title 118
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Nef induces Programmed Death (PD)-1 expression through a p38 MAPK dependent mechanism
###end article-title 118
###begin article-title 119
###xml 104 107 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
Inefficient Nef-mediated downmodulation of CD3 and MHC-I correlates with loss of CD4+T cells in natural SIV infection
###end article-title 119
###begin article-title 120
###xml 42 77 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Rodent cells support key functions of the human immunodeficiency virus type 1 pathogenicity factor Nef
###end article-title 120
###begin article-title 121
###xml 130 135 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Modulation of specific surface receptors and activation sensitization in primary resting CD4+ T lymphocytes by the Nef protein of HIV-1
###end article-title 121

